Total Synthesis of Rucaparib

Jinjae Park, Cheol Hong Cheon

Research output: Contribution to journalArticlepeer-review

3 Citations (Scopus)


A concise total synthesis of rucaparib, an FDA-approved drug for ovarian and prostate cancers, is reported. The Heck reaction of the commercially available aryl iodide with acrylonitrile provided the desired (E)-2-aminocinnamonitrile derivative. A subsequent imino-Stetter reaction of the aldimine derived from 2-aminocinnamonitrile and aldehyde furnished indole-3-acetonitrile bearing the desired substituents at appropriate positions. The construction of the final azepinone scaffold via reduction of the nitrile group followed by seven-membered lactamization afforded rucaparib. Notably, the synthesis of rucaparib is achieved using commercially available starting materials in only three separation operations with 54% overall yield.

Original languageEnglish
Pages (from-to)4813-4817
Number of pages5
JournalJournal of Organic Chemistry
Issue number7
Publication statusPublished - 2022 Apr 1

ASJC Scopus subject areas

  • Organic Chemistry


Dive into the research topics of 'Total Synthesis of Rucaparib'. Together they form a unique fingerprint.

Cite this